Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ImmunoGen to receive patent coverage for humanization technology

Jan. 29, 1997

BMS/Xenova collaborate on drug discovery

Jan. 27, 1997

Allelix/Aurora enter drug discovery collaboration

Jan. 27, 1997

Oncor technology covered by U.S. patent

Jan. 24, 1997

Collaborators sought for gene therapy technology

Jan. 23, 1997

NIH seeks licensees for perilipins

Jan. 23, 1997

New tool for studying phosphodiesterase receptors

Jan. 23, 1997

ArQule and Abbott extend collaboration

Jan. 22, 1997

NIH offers sterile lyophilization product

Jan. 22, 1997

TheraTech licenses pulmonary delivery devices

Jan. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...